These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 499332)
1. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Herlyn D; Herlyn M; Steplewski Z; Koprowski H Eur J Immunol; 1979 Aug; 9(8):657-9. PubMed ID: 499332 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090 [TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies to human melanoma-associated antigens. Imai K; Ng AK; Ferrone S J Natl Cancer Inst; 1981 Mar; 66(3):489-96. PubMed ID: 6162991 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to human tumor antigens. Steplewski Z Transplant Proc; 1980 Sep; 12(3):384-7. PubMed ID: 7222217 [No Abstract] [Full Text] [Related]
5. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198 [TBL] [Abstract][Full Text] [Related]
6. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma. Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400 [TBL] [Abstract][Full Text] [Related]
7. Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells. Steplewski Z; Chang TH; Herlyn M; Koprowski H Cancer Res; 1981 Jul; 41(7):2723-7. PubMed ID: 7248940 [TBL] [Abstract][Full Text] [Related]
8. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen. Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221 [TBL] [Abstract][Full Text] [Related]
9. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis. Woodhouse CS; Morgan AC Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860 [TBL] [Abstract][Full Text] [Related]
10. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas. Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells. Herlyn D; Powe J; Ross AH; Herlyn M; Koprowski H J Immunol; 1985 Feb; 134(2):1300-4. PubMed ID: 3965572 [TBL] [Abstract][Full Text] [Related]
12. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody. Eisenthal A; Cameron RB; Rosenberg SA J Immunol; 1990 Jun; 144(11):4463-71. PubMed ID: 2111349 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma. Munn DH; Cheung NK Cancer Res; 1987 Dec; 47(24 Pt 1):6600-5. PubMed ID: 3499978 [TBL] [Abstract][Full Text] [Related]
14. Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. Herlyn M; Clark WH; Mastrangelo MJ; Guerry DP; Elder DE; LaRossa D; Hamilton R; Bondi E; Tuthill R; Steplewski Z; Koprowski H Cancer Res; 1980 Oct; 40(10):3602-9. PubMed ID: 6159966 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of tumor growth inhibition. Steplewski Z; Herlyn D; Lubeck M; Kimoto Y; Herlyn M; Koprowski H Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386 [No Abstract] [Full Text] [Related]
16. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE; Spits H J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458 [TBL] [Abstract][Full Text] [Related]
17. The monoclonal antibody CJA3 down-regulates the susceptibility of human tumor cell lines to natural cell-mediated cytotoxicity. Allen JI; Ferrone S; Boue D; Kay NE J Immunol; 1986 Mar; 136(6):2318-22. PubMed ID: 3950415 [TBL] [Abstract][Full Text] [Related]
18. Reactivity of monoclonal anti-melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Steplewski Z; Herlyn M; Herlyn D; Clark WH; Koprowski H Eur J Immunol; 1979 Jan; 9(1):94-6. PubMed ID: 374094 [TBL] [Abstract][Full Text] [Related]
19. Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes. Primus FJ; Finch MD; Masci AM; Schlom J; Kashmiri SV Cancer Res; 1993 Jul; 53(14):3355-61. PubMed ID: 8324746 [TBL] [Abstract][Full Text] [Related]